Inventor · disambiguated record
Hongsheng Su
Also filed as: SU HONGSHENG
8 granted patents·8 pending applications·121 citations·filing 1994–2021
87Inventor score
Files withJIANGSU GENSCIENCES INC3KIADIS PHARMA CANADA INC3BIOMARIN PHARM INC2AMPSOURCE BIOPHARMA SHANGHAI INC1CELMED BIOSCIENCE INC1
Top patents by PatentIndex Score
16 records- 0186US8383672B2Halogenated rhodamine derivatives and applications thereofKIADIS PHARMA CANADA INC·Filed 2011·Granted Feb 26, 2013·10 cites·13 claims
- 0282US6841375B2Flavobacterium heparinum expression systemBIOMARIN PHARM INC·Filed 2001·Granted Jan 11, 2005·15 cites·9 claims
- 0374US5919693ANucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinumIBEX TECHNOLOGIES CORP·Filed 1997·Granted Jul 6, 1999·44 cites·12 claims
- 0472US7560574B2Halogenated rhodamine derivatives and applications thereofCELMED BIOSCIENCES INC·Filed 2002·Granted Jul 14, 2009·8 cites·1 claims
- 0570US5681733ANucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinumIBEX TECHNOLOGIES·Filed 1994·Granted Oct 28, 1997·43 cites·6 claims
- 0670US2009176869A1Halogenated Rhodamine Derivatives and Applications ThereofCELMED BIOSCIENCE INC·Filed 2009·Application pending·0 cites
- 0769US9636363B2Halogenated rhodamine derivatives and applications thereofKIADIS PHARMA CANADA INC·Filed 2013·Granted May 2, 2017·1 cites·9 claims
- 0855US2005153398A1Flavobacterium heparinum expression systemBIOMARIN PHARM INC·Filed 2004·Application pending·0 cites
- 0954US2011021616A1Halogenated rhodamine derivatives and applications thereofKIADIS PHARMA CANADA INC·Filed 2010·Application pending·0 cites
- 1048US2022000984A1Glp1-fc fusion protein and conjugate thereofJIANGSU GENSCIENCES INC·Filed 2019·Application pending·0 cites
- 1145US2023272030A1Insulin-fc fusion protein and application thereofJIANGSU GENSCIENCES INC·Filed 2021·Application pending·0 cites
- 1243US2009092578A1Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereofSU HONGSHENG·Filed 2007·Application pending·0 cites
- 1340US11471513B2Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of sameAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2016·Granted Oct 18, 2022·0 cites·4 claims
- 1440US2022323590A1Improved fix fusion protein and conjugate and use thereofJIANGSU GENSCIENCES INC·Filed 2020·Application pending·0 cites
- 1539US2002182201A1Matrix stabilized enzyme crystals and methods of useFiled 2002·Application pending·0 cites
- 1635US12440572B2FVIII fusion protein and use thereofZHENGZHOU GENSCIENCES INC·Filed 2019·Granted Oct 14, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Hongsheng Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →